Last reviewed · How we verify

NCT06570070

AI-powered Chatbot vs. Human Counselors in Smoking Cessation

Not yet recruiting NA Last updated 26 August 2024
What this trial tests

NA trial testing 5A's/5R's advice in Smoking Cessation in 300 participants. Not yet recruiting.

Timeline
1 September 2024
Primary endpoint
20 June 2025
30 December 2025

Quick facts

Lead sponsorBeijing Normal University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment300
Start date1 September 2024
Primary completion20 June 2025
Estimated completion30 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Normal University

Who can join

18 and older, any sex, with Smoking Cessation or Mobile Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore the feasibility and preliminary effectiveness of AI-powered chatbot support in community smokers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 5A's/5R's advice

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other Beijing Normal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06570070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing